Antenatal fetal VEGF therapy to promote pulmonary maturation in a preterm rabbit model.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 20181445)

Published in Early Hum Dev on February 23, 2010

Authors

A Debeer1, L Sbragia, K Vrancken, A Hendriks, X Roubliova, J Jani, G Naulaers, P Carmeliet, J Deprest

Author Affiliations

1: Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium. anne.debeer@uzleuven.be <anne.debeer@uzleuven.be>

Articles by these authors

In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med (2001) 5.28

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66

Molecular mechanisms of blood vessel growth. Cardiovasc Res (2001) 3.94

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med (2001) 2.66

Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol (1999) 2.56

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost (2003) 2.49

Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med (2001) 2.46

Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A (2001) 2.42

Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation (1995) 2.38

Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19

Combined spinal-epidural anesthesia for cesarean delivery: dose-dependent effects of hyperbaric bupivacaine on maternal hemodynamics. Anesth Analg (2006) 2.14

Fetal magnetic resonance imaging: luxury or necessity? Ultrasound Obstet Gynecol (2006) 2.14

VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med (2000) 2.13

Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol (2000) 2.11

Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation (1999) 1.97

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94

A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development (2001) 1.92

PR39, a peptide regulator of angiogenesis. Nat Med (2000) 1.90

Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood (1998) 1.81

Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis (2008) 1.70

Acceptance, reliability and confidence of diagnosis of fetal and neonatal virtuopsy compared with conventional autopsy: a prospective study. Ultrasound Obstet Gynecol (2012) 1.68

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1996) 1.66

Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res (2000) 1.65

The endoscopic localization of endometrial implants in the ovarian chocolate cyst. Fertil Steril (1994) 1.64

Pain experienced during transvaginal ultrasound, saline contrast sonohysterography, hysteroscopy and office sampling: a comparative study. Ultrasound Obstet Gynecol (2008) 1.61

Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest (1998) 1.55

Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci U S A (1996) 1.54

Generation and characterization of urokinase receptor-deficient mice. J Clin Invest (1996) 1.54

Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature (1997) 1.50

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48

A mouse model for Zellweger syndrome. Nat Genet (1997) 1.43

Hernia repair: the search for ideal meshes. Hernia (2009) 1.42

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation. Br J Cancer (2008) 1.41

Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature. Ultrasound Obstet Gynecol (2014) 1.39

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38

Developmental pharmacology: neonates are not just small adults... Acta Clin Belg (2008) 1.36

Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol (2000) 1.33

Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A (2002) 1.31

Heterogeneous vascular dependence of tumor cell populations. Am J Pathol (2001) 1.31

Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res (2001) 1.30

Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation (1998) 1.29

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J (2001) 1.29

Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood (2001) 1.25

Development of targeted angiogenic medicine. J Thromb Haemost (2008) 1.22

Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem Biophys Res Commun (2004) 1.22

Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res (2003) 1.22

Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest (1998) 1.20

Congenital diaphragmatic hernia. Eur Respir J (2011) 1.20

Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost (2000) 1.20

Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol (2007) 1.20

Tissue factor expression during human and mouse development. Am J Pathol (1996) 1.19

Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). Cancer Res (1999) 1.19

Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J Biol Chem (2001) 1.18

Pelvic floor descent in females: comparative study of colpocystodefecography and dynamic fast MR imaging. J Magn Reson Imaging (1999) 1.15

Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol Cell Biol (2001) 1.15

Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery. Int J Obstet Anesth (2012) 1.14

Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest (2000) 1.13

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation (1999) 1.13

Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract (2005) 1.12

Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study. Ultrasound Obstet Gynecol (2007) 1.11

The value of fast MR imaging as an adjunct to ultrasound in prenatal diagnosis. Eur Radiol (2003) 1.10

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol (1998) 1.10

Prenatal prediction of survival in isolated left-sided diaphragmatic hernia. Ultrasound Obstet Gynecol (2006) 1.10

Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest (1998) 1.08

Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A (1999) 1.08

Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids. J Biol Chem (2000) 1.07

Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ Res (2001) 1.06

Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology (1989) 1.06

Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. Blood (2000) 1.05

Developmental biology. One cell, two fates. Nature (2000) 1.03

Persistence of polypropylene mesh anisotropy after implantation: an experimental study. BJOG (2011) 1.02

The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse. J Anat (2001) 1.02

CA 125 concentrations in ovarian 'chocolate' cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Hum Reprod (1992) 1.01

Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol Neonate (2004) 1.01

Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol (2008) 1.01

Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol (2001) 1.00

Growing better blood vessels. Nat Biotechnol (2001) 1.00

Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res (2001) 0.99

Gastroschisis: small hole, big cost. J Pediatr Surg (2002) 0.99

Value of prenatal magnetic resonance imaging in the prediction of postnatal outcome in fetuses with diaphragmatic hernia. Ultrasound Obstet Gynecol (2008) 0.98

Carbon dioxide pneumoamnios causes acidosis in fetal lamb. Fetal Diagn Ther (1994) 0.98

Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG (2009) 0.98

Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development. Biochem Biophys Res Commun (2001) 0.98

Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth (2007) 0.97

Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost (2010) 0.97

Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil Steril (1998) 0.96

Antenatal and postnatal management of congenital cystic adenomatoid malformation. Paediatr Respir Rev (2012) 0.96

The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol (2003) 0.96

Associated malformations and chromosomal anomalies in 42 cases of prenatally diagnosed diaphragmatic hernia. Am J Med Genet (2001) 0.96

The effect of imatinib mesylate on the contractility of isolated rabbit myometrial strips. Gynecol Obstet Invest (2006) 0.95

Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. J Clin Invest (1999) 0.95

Covariates of tramadol disposition in the first months of life. Br J Anaesth (2008) 0.94

Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost (2006) 0.94

Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J Cell Biol (1997) 0.93

Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet (2008) 0.93